須江聡一郎 (Soichiro Sue) - マイポータル

基本情報

所属: 横浜市立大学附属病院消化器内科講師

学位: 博士（医学）(横浜市立大学)

J-GLOBAL ID: 201701016475930147
researchmap会員ID: 7000019245

Helicobacter pyloriと胃癌に関連した研究を主に行っています。
Helicobacter pylori除菌の臨床研究を含め、多数の特定臨床研究の研究責任医師を務め、胃発がん抑制を目的とした治療の開発のための研究に積極的に取り組んでいます。

研究キーワード

研究分野

ライフサイエンス / 消化器内科学 /

経歴

横浜市立大学附属病院消化器内科, 講師

学歴

- 現在

横浜市立大学大学院医学研究科博士課程修了

受賞

論文

Proton Pump Inhibitor-Induced Fundic Gland Polyps With Massive Bleeding Regressed on Alternative Histamine 2 Receptor Antagonist Therapy.

Ryosuke Ikeda, Hiroaki Kaneko, Hiroki Sato, Yuto Matsuoka, Tomomi Hamaguchi, Aya Ikeda, Yoshihiro Goda, Soichiro Sue, Kuniyasu Irie, Shin Maeda

DEN open 6(1) e70273 2026年4月
Feasibility of Endoscopic Closure Method Using Low Cost Clips With Thread for Post Gastric Endoscopic Submucosal Dissection: A Pilot Study.

Ryosuke Ikeda, Hiroaki Kaneko, Hiroki Sato, Yuto Matsuoka, Tomomi Hamaguchi, Aya Ikeda, Yoshihiro Goda, Soichiro Sue, Kuniyasu Irie, Shin Maeda

JGH open : an open access journal of gastroenterology and hepatology 10(3) e70376 2026年3月
Risk factors for gastric cancer diagnosed more than 10 years after eradication therapy of Helicobacter pylori.

Sho Onodera, Soichiro Sue, Hiroaki Kaneko, Yushi Kanemaru, Yoshimasa Suzuki, Hiroki Sato, Aya Ikeda, Ryosuke Ikeda, Yoshihiro Goda, Kuniyasu Irie …

Scandinavian journal of gastroenterology 1-10 2026年1月18日
Development of a novel PIK3CA-mutated pancreatic tumor mouse model and evaluation of the therapeutic effects of a PI3K inhibitor.

Yoshimasa Suzuki, Makoto Sugimori, Yushi Kanemaru, Sho Onodera, Hiromi Tsuchiya, Aya Ikeda, Ryosuke Ikeda, Yoshihiro Goda, Hiroaki Kaneko, Kuniyasu Irie …

PloS one 20(7) e0326491 2025年
Amoebic colitis insufficient to metronidazole monotherapy.

Ryosuke Ikeda, Hiroaki Kaneko, Hiroki Sato, Hideyuki Anan, Aya Ikeda, Yoshihiro Goda, Soichiro Sue, Kuniyasu Irie, Shin Maeda

Clinical journal of gastroenterology 18(2) 310-313 2024年12月12日
Using a Quality Management System and Risk-based Approach in Observational Studies to Obtain Robust Real-World Evidence.

Reo Tanoshima, Naoko Inagaki, Manabu Nitta, Soichiro Sue, Sayuri Shimizu, Tatsuya Haze, Kotaro Senuki, Chihiro Sano, Hajime Takase, Makoto Kaneko …

Therapeutic innovation & regulatory science 58(6) 1006-1013 2024年11月
Antibiotic Susceptibility-Guided Concomitant Therapy Regimen with Vonoprazan, High-Dose Amoxicillin, Clarithromycin, and Metronidazole for Helicobacter pylori Eradication as Fourth-Line Regimen: An Interventional Study.

Soichiro Sue, Takeshi Sato, Mao Matsubayashi, Hiroaki Kaneko, Kuniyasu Irie, Shin Maeda

Microorganisms 12(10) 2024年10月21日
Risk factors for unclear margin in cold snare polypectomy for colorectal polyp.

Ryosuke Ikeda, Hiroaki Kaneko, Hiroki Sato, Hideyuki Anan, Yuichi Suzuki, Aya Ikeda, Yoshihiro Goda, Soichiro Sue, Kuniyasu Irie, Shin Maeda

European journal of gastroenterology & hepatology 36(12) 1404-1409 2024年9月20日
Activation of STING in pancreatic cancer-associated fibroblasts exerts an antitumor effect by enhancing tumor immunity.

Yoshimasa Suzuki, Takeshi Sato, Makoto Sugimori, Yushi Kanemaru, Sho Onodera, Hiromi Tsuchiya, Yoshinori Nakamori, Sho Tsuyuki, Aya Ikeda, Ryosuke Ikeda …

Scientific reports 14(1) 17071-17071 2024年7月24日
A Novel Characteristic Gastric Mucus Named "Web-like Mucus" Potentially Induced by Vonoprazan.

Hiroaki Kaneko, Hiroki Sato, Yuichi Suzuki, Aya Ikeda, Hirofumi Kuwashima, Ryosuke Ikeda, Takeshi Sato, Kuniyasu Irie, Soichiro Sue, Shin Maeda

Journal of clinical medicine 13(14) 2024年7月11日
Single-Arm, Prospective, Interventional Study of Helicobacter pylori Eradication Rescue Therapy with Rifabutin, Metronidazole, and Vonoprazan.

Soichiro Sue, Ryosuke Ikeda, Aya Ikeda, Hiroki Sato, Hiroaki Kaneko, Kuniyasu Irie, Shin Maeda

Journal of clinical medicine 13(13) 2024年6月27日
Comparison of metronidazole versus clarithromycin in first-line vonoprazan-based triple therapy for Helicobacter pylori: A multicenter randomized trial in Japan.

Soichiro Sue, Hiroyuki Oka, Yosuke Kunishi, Yuichi Suzuki, Shingo Suzuki, Takashi Kaneko, Kazuo Komatsu, Makoto Naito, Yoshio Kato, Tomohiko Sasaki …

JGH open : an open access journal of gastroenterology and hepatology 8(4) e13069 2024年4月
The usefulness of texture and color enhancement imaging to identify the minor papilla orifice.

Yoshihiro Goda, Kuniyasu Irie, Hideyuki Anan, Yuichi Suzuki, Aya Ikeda, Ryosuke Ikeda, Hiroaki Kaneko, Soichiro Sue, Haruo Miwa, Shin Maeda

DEN open 4(1) e358 2024年4月
Risk assessment of metachronous gastric cancer after endoscopic submucosal dissection based on endoscopic intestinal metaplasia.

Chino Iizuka, Soichiro Sue, Sho Onodera, Aya Ikeda, Ryosuke Ikeda, Yoshihiro Goda, Kuniyasu Irie, Hiroaki Kaneko, Shin Maeda

JGH open : an open access journal of gastroenterology and hepatology 7(11) 783-789 2023年11月
Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori.

Soichiro Sue, Yuichi Suzuki, Tomohiko Sasaki, Hiroaki Kaneko, Kuniyasu Irie, Kazuto Komatsu, Shin Maeda

Journal of clinical medicine 12(17) 2023年8月22日
Vonoprazan and high-dose amoxicillin dual therapy for Helicobacter pylori first-line eradication: A single-arm, interventional study.

Soichiro Sue, Masaaki Kondo, Takeshi Sato, Hiroyuki Oka, Katsuyuki Sanga, Tsuyoshi Ogashiwa, Mao Matsubayashi, Hiroaki Kaneko, Kuniyasu Irie, Shin Maeda

JGH open : an open access journal of gastroenterology and hepatology 7(1) 55-60 2023年1月
Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Helicobacter pylori Eradication?

Soichiro Sue, Shin Maeda

Gut and liver 15(6) 799-810 2021年11月15日
NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice

Shin Maeda, Yohko Hikiba, Hiroaki Fujiwara, Tsuneo Ikenoue, Soichiro Sue, Makoto Sugimori, Mao Matsubayashi, Hiroaki Kaneko, Kuniyasu Irie, Tomohiko Sasaki …

Cancer Science 112(4) 1471-1480 2021年4月
Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy.

Soichiro Sue, Tomohiko Sasaki, Hiroaki Kaneko, Kuniyasu Irie, Masaaki Kondo, Shin Maeda

JGH open : an open access journal of gastroenterology and hepatology 5(2) 307-311 2021年2月
胃ESDにおける粘膜下層脂肪量の術前予測因子に関する検討

桑島拓史, 金子裕明, 露木翔, 杉森慎, 三箇克幸, 山田博昭, 須江聡一郎, 入江邦泰, 佐々木智彦, 近藤正晃 …

Gastroenterological Endoscopy 62(Suppl.1) 1294-1294 2020年8月

もっとみる

MISC

PREDICTIVE FACTORS OF SUBMUCOSAL ADIPOSE TISSUE VOLUME THAT CAUSE TECHNICAL DIFFICULTY DURING GASTRIC ESD

Hiroaki Kaneko, Sho Tsuyuki, Hirofumi Kuwashima, Hiroaki Yamada, Soichiro Sue, Kuniyasu Irie, Tomohiko Sasaki, Masaaki Kondo, Shin Maeda

GASTROINTESTINAL ENDOSCOPY 89(6) AB345-AB345 2019年6月
ROLE OF APOPTOSIS SIGNAL-REGULATING KINASE 1 IN NAFL-ASSOCIATED HEPATOCARCINOGENESIS IN MICE

Shin Maeda, Yohko Hikiba, Makoto Sugimori, Yoshihiro Kaneta, Soichiro Sue, Hiroaki Kaneko, Tomohiko Sasaki, Kuniyasu Irie, Masaaki Kondo, Makoto Chuma

GASTROENTEROLOGY 156(6) S1296-S1297 2019年5月
NF-kappa B signaling contributes to the expression of PD-L1 in pancreatic cancer

Yoshihiro Kaneta, Makoto Sugimori, Soichiro Sue, Wataru Shibata, Shin Maeda

CANCER SCIENCE 109 1398-1398 2018年12月
NAFLD becomes a promoter of cholangiocellular carcinoma in mice

Masatomo Kanno, Yoshihiro Kaneta, Soichiro Sue, Makoto Sugimori, Wataru Shibata, Shin Maeda

CANCER SCIENCE 109 110-110 2018年1月
Research for Intestine-specific homeobox (ISX) targeting drug in Gastric Cancer

Soichiro Sue, Wataru Shibata, Kei Nakajima, Makoto Sugimori, Masatomo Kanno, Yoshihiro Kaneda, Takeshi Sato, Shin Maeda

CANCER SCIENCE 109 611-611 2018年1月
EFFECTIVENESS OF PD-L1 INHIBITION AS A THERAPEUTIC OPTION OF CANCER IMMUNOTHERAPY IN PANCREATIC CANCER

Eri Kameta, Wataru Shibata, Takeshi Sato, Soichiro Sue, Shin Maeda

GASTROENTEROLOGY 152(5) S189-S189 2017年4月
INTESTINE-SPECIFIC HOMEOBOX (ISX) IS AN IMPORTANT REGULATOR FOR GASTRIC CARCINOGENESIS WITH POTENTIAL FOR MOLECULAR TARGET

Soichiro Sue, Wataru Shibata, Makoto Sugimori, Takeshi Sato, Eri Kameta, Shin Maeda

GASTROENTEROLOGY 152(5) S56-S56 2017年4月
A MULTICENTER, OPEN-LABEL, RANDOMIZED TRIAL OF VONOPRAZAN VERSUS PPI BASED 7-DAY TRIPLE THERAPY FOR THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION

Soichiro Sue, Hirohumi Kuwashima, Isao Arima, Marina Ogushi, Satoshi Nakao, Makoto Naito, Kazuto Komatu, Hiroaki Yamada, Hiroaki Kaneko, Toshihide Tamura …

GASTROENTEROLOGY 152(5) S250-S250 2017年4月
NAFLD EXACERBATES CHOLANGITIS AND BECOMES A PROMOTER OF CHOLANGIOCELLULAR CARCINOMA

Shin Maeda, Yohko Hikiba, Masatomo Kanno, Takeshi Sato, Soichiro Sue, Makoto Sugimori, Eri Kameta, Wataru Shibata

GASTROENTEROLOGY 152(5) S1183-S1183 2017年4月
LOSS OF E-CADHERIN EXPRESSION PROMOTES LOCAL PANCREATIC TUMOR PROGRESSION BUT DOESN'T CORRELATED WITH METASTATIC PHENOTYPE

Takeshi Sato, Wataru Shibata, Yohko Hikiba, Yuki Yamashita, Makoto Sugimori, Eri Kameta, Soichiro Sue, Shin Maeda

GASTROENTEROLOGY 152(5) S899-S899 2017年4月
次世代シークエンサーによる進行胃癌の遺伝子変異解析(Targeted DNA sequencing for advanced gastric carcinoma using next generation sequencing)

芝田渉, 津村祥子, 須江聡一郎, 佐藤健, 亀田英里, 杉森慎, 石井泰明, 山田博昭, 金子裕明, 佐々木智彦 …

日本胃癌学会総会記事 89回 251-251 2017年3月
E-Cadherin Is Dispensable for Pancreatic Development of Embryo but Required for Neonatal Pancreatic Growth in Mice

Takeshi Sato, Wataru Shibata, Yohko Hikiba, Yasuaki Ishii, Eri Kameta, Soichiro Sue, Shin Maeda

GASTROENTEROLOGY 150(4) S914-S914 2016年4月
Efficacy and Safety of Novel Class of Acid Suppressants: P-Cab-Based Amoxicillin and Clarithromycin 1 Week Triple Therapy as First Line Eradication of H. pylori in Japan. A Multicenter Study

Soichiro Sue, Isao Arima, Hirohumi Kuwashima, Katuyuki Sanga, Hiroyuki Oka, Yuniba Ishii, Masatomo Kanno, Masahiro Terada, Yuri Iwata, Yasuhiro Inokuchi …

GASTROENTEROLOGY 150(4) S880-S880 2016年4月
Efficacy and Safety of Novel Class of Acid Suppressants: P-Cab-Based Amoxicillin and Metronidazole 1 Week Triple Therapy as Second Line Eradication of H. pylori in Japan. A Multicenter Study

Soichiro Sue, Isao Arima, Hirohumi Kuwashima, Katuyuki Sanga, Hiroyuki Oka, Yuniba Ishii, Masatomo Kanno, Masahiro Terada, Yuri Iwata, Yasuhiro Inokuchi …

GASTROENTEROLOGY 150(4) S880-S880 2016年4月
Establishment of Metastatic Pancreatic Cancer Model That Can Monitor Tumor Burdens

Eri Kameta, Wataru Shibata, Takeshi Sato, Yasuaki Ishii, Soichiro Sue, Shin Maeda, Yohko Hikiba

GASTROENTEROLOGY 150(4) S627-S627 2016年4月
Roles of Intestine Specific Homeobox (ISX) for Gastric Carcinogenesis and Cancer Growth

Soichiro Sue, Wataru Shibata, Eri Kameta, Yasuaki Ishii, Takeshi Sato, Shin Maeda

GASTROENTEROLOGY 148(4) S566-S566 2015年4月
Activation of STAT3 Signaling Contributed to Helicobacter Associated Gastric Epithelial Proliferation and Inflammation In Vivo

Yasuaki Ishii, Wataru Shibata, Takeshi Sato, Eri Kameta, Soichiro Sue, Shin Maeda

GASTROENTEROLOGY 148(4) S102-S102 2015年4月
Overexpression of HER2 Converted the KRAS-Driven PanIN Lesions to IPMC Phenotype

Wataru Shibata, Hiroto Kinoshita, Takeshi Sato, Yasuaki Ishii, Soichiro Sue, Eri Kameta, Shin Maeda

GASTROENTEROLOGY 148(4) S373-S373 2015年4月
Diagnosis for Pancreatic Lesions Collected With the Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) by Next Generation Sequencing

Eri Kameta, Kazuya Sugimori, Yasuaki Ishii, Takeshi Sato, Soichiro Sue, Haruo Miwa, Tomohiro Ishii, Takashi Kaneko, Wataru Shibata, Shin Maeda

GASTROENTEROLOGY 148(4) S338-S338 2015年4月
Overexpression of HER2 Induces Ipmc Through the Activation of MAPK Pathway

Wataru Shibata, Hiroto Kinoshita, Soichiro Sue, Shin Maeda

GASTROENTEROLOGY 146(5) S496-S496 2014年5月

もっとみる

所属学協会

共同研究・競争的資金等の研究課題

腸上皮化生に対するISXを標的とした胃発癌化学予防治療の臨床応用

日本学術振興会科学研究費助成事業基盤研究(C) 2023年4月 - 2026年3月

須江聡一郎, 前田愼
ISXに着目した非H. pylori胃細菌叢除菌による胃発癌対策治療の確立

日本学術振興会科学研究費助成事業基盤研究(C) 2020年4月 - 2023年3月

須江聡一郎, 前田愼
エピジェネティックな変化を基盤とする新規胃発癌モデルの構築

日本学術振興会科学研究費助成事業基盤研究(C) 2019年4月 - 2022年3月

前田愼, 須江聡一郎
ISXに着目したヒト胃オルガノイド発癌モデル作成と胃癌治療への応用

日本学術振興会平成30年度若手研究若手研究 2018年4月 - 2020年3月

須江聡一郎
腸上皮化生と胃発癌におけるH.pylori誘導ホメオボックス遺伝子ISXの役割

日本学術振興会平成28年度若手研究(B) 若手研究(B) 2016年4月 - 2018年3月

須江聡一郎

須江聡一郎

基本情報

研究キーワード

研究分野

経歴

学歴

受賞

論文

MISC

所属学協会

共同研究・競争的資金等の研究課題

メニュー

共著者の一覧